Affichem, BloodLink and Mowoot win audience vote of European Health Catapult
Voting held on the first day of the EIT Health Summit
Affichem, BloodLink and Mowoot won in the Biotech, Digital Health and Medtech categories respectively in the audience voting segment of the European Health Catapult finals on 4 December, the first day of the EIT Health Summit.
After all the start-ups made their pitches for the audience on the first day of the Summit, these three won the most audience votes to receive the Public Awards of the European Health Catapult competition.
A professional jury was to make their decisions and award the top finalists in the competition on the last day of the Summit, 5 December.
The competitors, all promising healthcare start-ups, pitched their innovations in the European Health Catapult's year-long programme of training and competitions. They will gain the attention of investors, and the Public Awards and Jury winners will share prizes worth a total of EUR 135,000.
The Public Awards were announced at a gala dinner held on the first night of the EIT Health Summit.
About the Public Awards winners
Affichem: A biotech company whose mission is to design, develop and market innovative therapeutic molecules and theranostic markers for the treatment of cancer and neurodegenerative diseases.
BloodLink: Streamlines the sourcing and exchange of blood, and reduces blood shortages, by connecting all stakeholders on one online platform, which provides a safe, secure and cost efficient way for blood banks and hospitals to find and exchange blood across the nation.
Mowoot by Usmima: Reproduces the abdominal massage performed by physiotherapists to facilitate intestinal transit, the solution to chronic constipation that improves its effectiveness over time.
Catch up with the latest news from the EIT Community in the Newsroom.
Subscribe to the EIT Newsletter to get the best of the EIT Community's news in your inbox once each month.
Share this page
